Clinical trial
A Study of Ocrelizumab in Combination With Methotrexate in Patients With…
NCT00485589 · Genentech, Inc., Industry · Terminated
Key facts
| NCT number | NCT00485589 |
|---|---|
| Title | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) |
| Official title | A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab in Combination With Methotrexate (MTX) Compared to MTX Alone in Methotrexate- Naive Patients With Active Rheumatoid Arthritis |
| Acronym | FILM |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Roche Pharma AG Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Methotrexate, Ocrelizumab, Placebo |
| Enrollment | 613 |
| Start date | Jun 11, 2007 |
| Primary completion | Jan 29, 2010 |
| Completion | Aug 29, 2013 |
| First posted | Jun 13, 2007 |
| Last update posted | Nov 3, 2020 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: